NCT02770248View on ClinicalTrials.gov

24-hr Intraocular Pressure Control With SIMBRINZA ®

PHASE4CompletedINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

January 14, 2017

Study Completion Date

January 14, 2017

Conditions

Glaucoma

Interventions

DRUG

Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension

DRUG

Vehicle

Inactive ingredients used as a placebo for masking purposes

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY